HYPR (Hyperfine) Valuation Rank


HYPR Hyperfine Inc HYPR
78 GF Score
Price $1.47
GF Value $1.31
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Hyperfine Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Hyperfine Valuation Rank Related Terms

HYPR
78GF Score
Hyperfine Inc HYPR
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hyperfine (HYPR) Overvalued in 2026?

Based on GuruFocus' analysis, Hyperfine stock appears to be overvalued. The current stock price of $1.47 is trading 12.2% above its estimated GF Value™ of $1.31. GuruFocus considers Hyperfine to be Modestly Overvalued.

Key valuation signals for HYPR:

  • Valuation Rank:
  • GF Value™: $1.31 vs. price of $1.47 (12.2% above fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the HYPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hyperfine Business Description

Address 351 New Whitfield Street, Guilford, CT, USA, 06437
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
78GF Score

Get the complete analysis for HYPR

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.47
Price
$1.31
GF Value